RPG Life Sciences Cash Flow
- Market cap
- ₹4,487 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,953.14 – ₹3,662.14
In the year ended FY25, RPG Life Sciences generated ₹269 crore from operating activities, invested ₹179 crore and paid out ₹67.3 crore on financing activities. Net cash flow for the year was ₹22.43 crore. Free cash flow was ₹112 crore.
RPG Life Sciences cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 269 |
| Cash from investing activities | -179 |
| Cash from financing activities | -67.3 |
| Net cash flow | 22.43 |
| Capital expenditure | 157 |
| Free cash flow | 112 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
RPG Life Sciences cash flow — frequently asked questions
What is RPG Life Sciences' operating cash flow?
RPG Life Sciences' cash flow from operating activities was ₹269 crore in the year ended FY25.
What is RPG Life Sciences' free cash flow?
RPG Life Sciences' free cash flow — operating cash flow minus capital expenditure — was ₹112 crore in FY25, after capital expenditure of ₹157 crore.
How much did RPG Life Sciences spend on investing activities?
Net cash used in investing activities was ₹179 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade RPG Life Sciences With ATS
Track RPGLIFE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.